# Contact Us

Thank you for your interest in Boehringer Ingelheim. We welcome your queries and feedback.

### **Boehringer Ingelheim RCV GmbH & Co KG**

Dr.-Boehringer-Gasse 5-11

1121 Vienna, Austria

Telephone +43 1 80 105-0

[info.vie@boehringer-ingelheim.com](mailto:info.vie@boehringer-ingelheim.com)

- [Getting there with public transport](/content/sites/default/files/2025-02/G000_BG001%26CLD013_01_06%20Anfahrtsplan%20ENGLISH-Public.pdf "Directions with public transport"/index.html)

### Using public transport

To get from Vienna Airport to "Wien Hetzendorf", you can use the following public transport:

- **Express train S7**: This train runs approx. every 30 minutes (:19 and :48) from Vienna Airport to “Wien Mitte” (travel time 25 minutes)

- **City Airport Train (CAT)**: This train runs every 30 minutes (:07 and :37) from Vienna Airport to "Wien Mitte" (travel time 16 minutes)

- From "Wien Mitte" you can then take the S-Bahn lines S2 (towards Mödling), S3 or S4 (both towards Wiener Neustadt), which go directly to "Wien Hetzendorf".

- Hetzendorf station is located right next to our LSCC production building.

- If you take the exit "Boehringer Ingelheim" and follow the footpath along the company premises, you will reach in approx. 5 minutes (about 350m) the "Gate Nord" (address Belghofergasse 26, 1120), where we would like to welcome you at our Info Point.

### Further locations in Vienna

Some business units are located at nearby other sites:

**Boehringer Ingelheim**  
**BIG POINT Office Center**  
Altmannsdorfer Street 76  
1121 Vienna

**Boehringer Ingelheim**  
**Vienna Twin Towers**  
Wienerbergstrasse 11  
1100 Vienna

For the locations in the BIG POINT Office Center and in the Vienna Twin Towers, please use the registration option at the on-site reception.

### Choose a category for your concern *_Required._

- General
- Press/Media
- Adverse Event Human Pharma

If you suspect an adverse reaction to one of our **veterinary products,** [please click here](/content/at/en/veterinary-product-adverse-events/index.html)

#### Details of notification

- **Product name**
- **Batch number (Ch.-B./Lot)**
- **Used from - to**  
- **Reason for therapy**
- **Form of administration**
- **Daily dose**

#### Details of the affected person

- **Initials**
- **Gender**  
 - None  
 - Male  
 - Female  
 - Unknown

- **Age (Number)**
- **Unit (Age)**  
 - None  
 - Year  
 - Month  
 - Week  
 - Day  
 - Hour  
 - Minute

- **Age group**  
 - None  
 - 0 Days (Fetus)  
 - 1 - 31 Days  
 - 32 - 364 Days  
 - 1 - 12 Years  
 - 13 - 18 Years  
 - 19 – 59 Years  
 - 60 Years or older

- **Height**
- **Weight**

#### Details to statement

- Was it a serious event?  
 - No  
 - Yes, because it led to an unforeseen hospital admission or extension of a hospital stay?  
 - Yes, because it led to an immediately life-threatening condition?  
 - Yes, because it led to death?  
 - Yes, because it led to a congenital malformation, abnormality, or birth defect?  
 - Yes, because it led to permanent or severe disability or invalidity?  
 - Yes, because it was medically significant?  
 - Unknown

- Do you or your doctor see a possible connection between the event and the medication?  
 - Yes  
 - No

(What exactly happened? Course and outcome, start & stop date, first user?, information on accompanying medication and/or co-morbidities)

The company may contact you for further details regarding your report.

### Captcha

'I am human', Select in order to trigger the challenge, or to bypass it if you have an accessibility cookie

I am human.